Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.

$8.6M

Market Cap • 11/18/2024

2017

(7 years)
Founded

2018

(6 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Chicago

Headquarters • Illinois